Mechanism of Action: Inhibits the destruction of acetylcholine by cholinesterase Indications: Myasthenia Gravis (MG) Myasthenia gravis (MG) is an autoimmune disorder caused by the development of autoantibodies that destroy acetylcholine receptors in the neuromuscular junction, resulting in muscle weakness (Gilhus, 2016)
therefore it works better for weight loss is a reasonable hypothesis, not a proven fact
The combination of tesamorelin and retatrutide, despite its theoretical appeal, suits a narrow profile of researchers with specific goals and risk tolerance
Extended Activity: Due to reduced binding to IGF-binding proteins, IGF-1 LR3 may produce more prolonged receptor engagement than equivalent amounts of native IGF-1 in experimental systems, allowing for detailed study of dosetime relationships and cumulative effects on cell populations
Retatrutide metabolic benefits Retatrutide has demonstrated even more dramatic metabolic benefits, particularly for liver health and insulin sensitivity